Glofitamab,Obinutuzumab,Tocilizumab
roche
['glofitamab', 'mantle,(-dismantle)', 'obinu', 'lymphoma']
the use of a fixed-duration regimen of glofitamab several days after pretreatment with obinutuzumab was associated with high crs in heavily pretreated patients with relapsed or refractory mantle cell lymphoma. #mcl #ash22 
Home of the journal ONCOLOGY®, CancerNetwork® offers different perspectives on oncology/hematology through review articles, news, podcasts, blogs, and more.